Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Middle Norway Corona Study - Individual and Genetic Risk Factors for COVID-19 Infection.

NCT05638178 is registered in ClinicalTrials.gov with St. Olavs Hospital as lead sponsor.

NCT NCT05638178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05638178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Middle Norway Corona Study - Individual and Genetic Risk Factors for COVID-19 Infection.
Lead sponsor
St. Olavs Hospital
Phase
Observational
Overall status
Completed
Start date
May 1, 2020
Completion date
August 12, 2022
Enrollment
223 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

sars cov 2 infection, sars-cov-2 acute respiratory disease, sars-cov-2 sepsis